Mauna Kea Technologies SA
F:1MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mauna Kea Technologies SA
F:1MK
|
FR |
|
Whitehaven Coal Ltd
ASX:WHC
|
AU |
|
F
|
Fortescue Metals Group Ltd
XBER:FVJ
|
AU |
|
D
|
Deutsche Bank AG
DUS:DBK
|
DE |
|
California Resources Corp
F:1CLD
|
US |
|
J
|
J M Smucker Co
XBER:JM2
|
US |
|
NIO Inc
NYSE:NIO
|
CN |
|
D
|
Dillard's Inc
SWB:DL7A
|
US |
|
M
|
Man Wah Holdings Ltd
SWB:AAM
|
HK |
Mauna Kea Technologies SA
Mauna Kea Technologies makes Cellvizio, a medical imaging system used by doctors during endoscopy and other minimally invasive procedures. It lets physicians see tissue at microscopic detail inside the body in real time, so they can inspect suspicious areas without taking the patient out for a separate test. The company mainly sells to hospitals and specialist physicians in fields such as gastroenterology, pulmonology, urology, and surgery. The business makes money by selling its imaging consoles, probe-based imaging tools, and related disposable parts, along with service and support. In practice, a hospital buys the system, then keeps buying the probes and accessories needed for procedures. That gives Mauna Kea a mix of one-time equipment sales and repeat revenue from consumables. What sets the company apart is its role as a specialized add-on to existing endoscopy equipment rather than a full replacement for it. Cellvizio is designed to sit inside a doctor’s normal procedure workflow and add a closer look at tissue that standard scopes cannot provide. That makes Mauna Kea a niche medtech supplier focused on giving clinicians better live imaging at the point of care.
Mauna Kea Technologies makes Cellvizio, a medical imaging system used by doctors during endoscopy and other minimally invasive procedures. It lets physicians see tissue at microscopic detail inside the body in real time, so they can inspect suspicious areas without taking the patient out for a separate test. The company mainly sells to hospitals and specialist physicians in fields such as gastroenterology, pulmonology, urology, and surgery.
The business makes money by selling its imaging consoles, probe-based imaging tools, and related disposable parts, along with service and support. In practice, a hospital buys the system, then keeps buying the probes and accessories needed for procedures. That gives Mauna Kea a mix of one-time equipment sales and repeat revenue from consumables.
What sets the company apart is its role as a specialized add-on to existing endoscopy equipment rather than a full replacement for it. Cellvizio is designed to sit inside a doctor’s normal procedure workflow and add a closer look at tissue that standard scopes cannot provide. That makes Mauna Kea a niche medtech supplier focused on giving clinicians better live imaging at the point of care.
